The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register

INTRODUCTION: SARS-CoV-2 pandemic is especially compromising for patients with autoimmune diseases with or without immunomodulatory treatment. This study aimed to investigate the longitudinal changes in the health care of patients with immune-mediated neuropathies during the COVID-19 pandemic. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Hieke, Alina, Spenner, Marie, Schmitz, Fynn, Schumacher, Aurelian, Schröder, Maximilian, Klimas, Rafael, Sgodzai, Melissa, Brünger, Jil, Grüter, Thomas, Gold, Ralf, Pitarokoili, Kalliopi, Fisse, Anna Lena, Motte, Jeremias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778453/
https://www.ncbi.nlm.nih.gov/pubmed/36550388
http://dx.doi.org/10.1007/s00415-022-11527-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778453/
https://www.ncbi.nlm.nih.gov/pubmed/36550388
http://dx.doi.org/10.1007/s00415-022-11527-8

Ejemplares similares